Cartesian Therapeutics, Inc. (RNAC) vs Sutro Biopharma, Inc. (STRO)
- Cartesian Therapeutics, Inc. RNAC 6.27 −4.71%
- Sutro Biopharma, Inc. STRO 10.94 −4.54%
Cartesian Therapeutics, Inc. and Sutro Biopharma, Inc. are both Biotechnology companies. Cartesian Therapeutics, Inc. and Sutro Biopharma, Inc. are of similar size ($199.1M and $190.0M). Sutro Biopharma, Inc. grew revenue faster over the last twelve months: −56.3% against −94.8%. Cartesian Therapeutics, Inc. has the higher net margin (0.00% vs −395.3%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Cartesian Therapeutics, Inc. leads on 9 and Sutro Biopharma, Inc. on 6.
Valuation
Profitability
| Metric | RNAC | STRO | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 65.16% |
| Operating margin | 0.00% | (319.57%) | 0.00% |
| Net margin | 0.00% | (395.25%) | 0.00% |
| Free cash flow margin | 0.00% | (318.63%) | 0.00% |
| Return on equity | 236.88% | 266.76% | (56.36%) |
| Return on assets | (42.77%) | (79.08%) | (48.04%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack